This invention relates to compounds that are agonists of the muscarinic M1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula 1, or a salt thereof, wherein Q, R
申请公布号
AU2015213900(A1)
申请公布日期
2016.08.11
申请号
AU20150213900
申请日期
2015.02.06
申请人
HEPTARES THERAPEUTICS LIMITED
发明人
BROWN, GILES ALBERT;CANSFIELD, JULIE ELAINE;CONGREVE, MILES STUART;O'BRIEN, MICHAEL ALISTAIR;PICKWORTH, MARK;RACKHAM, MARK DAVID;TEHAN, BENJAMIN GERALD;TEOBOLD, BARRY JOHN
